Patents Assigned to Universite de Rennes
  • Publication number: 20240116923
    Abstract: The present invention relates to a compound of the following general formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, for use as drug for inhibiting ferroptosis.
    Type: Application
    Filed: January 25, 2022
    Publication date: April 11, 2024
    Applicants: Seabelife, Centre National de la Recherche Scientifique (CNRS), Sorbonne Universite, Institut National de la Santé et de la Recherche Médicale (INSERM), Université Claude Bernard Lyon 1, Universite de Rennes 1
    Inventors: Stéphane BACH, Arnaud COMTE, Claire DELEHOUZE, Marie-Thérèse DIMANCHE-BOITREL, Peter GOEKJIAN
  • Publication number: 20240116876
    Abstract: The present invention provides SOCE inhibitors that are useful as therapeutic agents in a variety of applications. The present invention also relates to pharmaceutical compositions, products and kits comprising such SOCE inhibitors, and methods of using the SOCE inhibitors in the treatment of a variety of diseases.
    Type: Application
    Filed: May 19, 2021
    Publication date: April 11, 2024
    Applicants: Institut National de la Santé et de la Recherche Médicale, Universite de Bretagne Occidentale, Ecole Nationale Superieure de Chimie de Rennes, Institut National des Sciences Appliquees de Rennes, Universite Nangui Abrogoua, Centre National de la Recherche Scientifique, Universite de Rennes 1
    Inventors: Jean Pierre Bazureau, Déliko Camille Dago, Lou Anna Voli, Olivier Mignen, Christophe Brigaudeau, Yves-Alain Berko
  • Patent number: 11618829
    Abstract: The present invention concerns a solid nanocomposite material consisting of a polymer-matrix in which are dispersed alkali metal, hydronium or ammonium salts of polyanionic components, wherein the polymer-matrix comprises at least a linear or branched polymer or copolymer containing one or several poly(ethylene oxide) (PEO) chains, said polymer or copolymer being optionally crosslinked and each PEO chain having at least 4 ethylene oxide monomer units. The present invention relates also to a photonic, e.g. optoelectronic, device comprising such a nanocomposite material. Such material and device can be used as phosphorescence emitter, for crop growth lighting or for generating singlet oxygen.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: April 4, 2023
    Assignees: Universite de Rennes 1, Centre National de la Recherche Scientifique (CNRS), Universidade de Franca—UNIFRAN
    Inventors: Yann Molard, Maria De Los Angeles Amela-Cortes, Malo Robin, Stephane Cordier, Eduardo Ferreira Molina
  • Patent number: 11171250
    Abstract: A shielding element comprises a rigid substrate and at least one electrically conductive two-dimensional structure which is placed on one of the faces of the substrate. The substrate and the electrically conductive two-dimensional structure are such that the shielding element has optical-transmission and shielding-efficiency values at least one of which varies between two zones of the shielding element. Such a shielding element enables easier assembly of a detection system comprising multiple optical sensors.
    Type: Grant
    Filed: May 22, 2017
    Date of Patent: November 9, 2021
    Assignees: Safran Electronics & Defense, Centre National de la Recherche Scientifique-CNRS, Universite de Rennes 1
    Inventors: Cyril Dupeyrat, Patrice Foutrel, Philippe Besnier, Xavier Castel, Yonathan Corredores
  • Publication number: 20200208030
    Abstract: Hydrocarbon copolymer P comprising 2 alkoxysilane end groups F1 and F2 of formulae: —F1 : (R?O)3-tRtSi—R?—NH—C(O)O—(CH2)g1— and F2: —(CH2)d1—OC(O)—NH—R?—SiRtOR?)3-t; or —F1: (R?O)3-tRtSi—R?—NR??—C(O)—NH—(CH2)g1— and F2: —(CH2)d1—NH—C(O)—NR??—R?—SiRt(OR?)3-t; or —F1: (R?O)3-tRtSi—R?—NR??—C(O)—(CH2)g2— and F2: —(CH2)d2C(O)—NR??—R?—SiRt(OR?)3-t; wherein t is 0, 1 or 2; g1 and d1 are 1, 2 or 3; g2 and d2 are 0, 1, 2 or 3; R and R? represent a C1-C4 alkyl; R? is a C1-C4 alkylene radical; R?? is method for producing the copolymer, by heating a statistical bipolymer A: poly(butadiene-isoprene), poly(butadiene-myrcene) or poly(butadiene-farnesene); and heating the formed product, in the presence of a chain transfer agent of formula (C) and adhesive composition of the copolymer and a crosslinking catalyst.
    Type: Application
    Filed: May 22, 2018
    Publication date: July 2, 2020
    Applicants: BOSTIK SA, Centre National De La Recherche Scientifique, Universite De Rennes 1
    Inventors: Guillaume MICHAUD, Frederic SIMON, Stephane FOUQUAY, Xiaolu MICHEL, Jean-Francois CARPENTIER, Sophie GUILLAUME
  • Patent number: 10663554
    Abstract: The invention relates to a module (6) for producing an MRI and/or MRS reference signal (S0), characterized in that the module comprises: a first receiving input (621) for receiving of an MRI and/or MRS synchronization signal (S3), a second receiving input (612) for receiving of a time signal (S8) of external stimulation, supply means (62) for supplying of a prescribed signal (RV) representing an MRI and/or MRS virtual object (RVV), generating means for generating of the MRI and/or MRS reference signal (S0), for temporally varying the MRI and/or MRS reference signal (S0) in the same way as a time characteristic determined from the time signal (S8) of external stimulation and in synchronization with the MRI and/or MRS synchronization signal (S3), a supply output (632) for supplying of the MRI and/or MRS reference signal (S0).
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: May 26, 2020
    Assignees: Universite De Rennes 1, Institut National de la Sante et de la Recherche Medicale (INSERM), Fondat Region Ouest Ligue Cancer
    Inventors: Hervé Saint-Jalmes, Giulio Gambarota
  • Publication number: 20190390017
    Abstract: A process for preparing a polyaminoborane comprising reacting at least one monomer with an aminoborane, wherein the at least one monomer is selected from the group consisting of ammonia, a primary amine and a substituted or unsubstituted hydrazine; and wherein the aminoborane comprises a borane substituted by a secondary amino group; polyaminoboranes obtainable by said process; use of said polyaminoboranes for the preparation of a ceramic precursor or a ceramic, the production of boron nitride, or the storage and/or production of dihydrogen; ceramic precursors, ceramics, hydrogen cells or energy materials comprising said polyaminoboranes.
    Type: Application
    Filed: January 30, 2018
    Publication date: December 26, 2019
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Universite de Rennes 1
    Inventors: Gilles Alcaraz, Carlos Antonio De Albuquerque Pinheiro, Claire Roiland
  • Publication number: 20190282563
    Abstract: The present invention provides nine selective c-FLIP inhibitors that are useful in the treatment of cancer, alone or in combination with other chemotherapeutic agents, in particular with TRAIL-based chemotherapeutic agents. The present invention also relates to pharmaceutical compositions and kits comprising at least one of the nine selective c-FLIP inhibitors and their use in methods for the treatment of cancer, in particular to overcome chemoresistance or to improve sensitivity of tumors to TRAIL-based therapy.
    Type: Application
    Filed: November 17, 2017
    Publication date: September 19, 2019
    Applicants: Centre National de la Recherche Scientifique, Universite de Rennes 1, Universite d'Orleans
    Inventors: Katherine YAACOUB, Thierry GUILLAUDEUX, Richard DANIELLOU, Pierre LAFITE, Samia ACI-SECHE, Pascal BONNET
  • Patent number: 10220112
    Abstract: The present invention provides cyclic antimicrobial pseudopeptides that are useful in a variety of applications. Also provided are pharmaceutical compositions, products and kits comprising such cyclic antimicrobial peptides and methods of using these antimicrobial peptides for modifying infectivity, killing microorganisms or inhibiting microbial growth or function and for preventing and/or treating an infection or contamination caused by such microorganisms.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: March 5, 2019
    Assignees: Universite de Rennes 1, Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale
    Inventors: Olivia Solecki, Amor Mosbah, Michèle Baudy-Floch, Brice Felden
  • Patent number: 10106645
    Abstract: 1) Hydrocarbon polymer having two azlactone end groups F1 is formula (IIa) and F2 is formula (IIb): g and d are 0, 1, 2 or 3; R14 and R15 are C1-C4 or a cyclohexyl radical; R1 to R12 represents hydrogen or alkyl with 1 to 22 carbon atoms; x and y are integers, x+y is 0 to 2; R13 is oxygen or sulphur or divalent —CH2— n1, n2, m, p1 and p2 are an integer or equal to 0 and such that the molecular weight Mn of the polymer of formula (I) is between 400 and 100 000 g/mol; a process for preparation of the polymer; and use as adhesive in mixture with an amino compound with at least two amine groups.
    Type: Grant
    Filed: July 18, 2017
    Date of Patent: October 23, 2018
    Assignees: BOSTIK SA, Universite de Rennes I, Centre National de la Recherche Scientifique
    Inventors: Guillaume Michaud, Frederic Simon, Stephane Fouquay, Elise Vanbiervliet, Sophie Guillaume, Jean-Francois Carpentier
  • Patent number: 10084548
    Abstract: A method is provided for transmitting a sequence of data symbols including at least two data symbols of distinct values, delivering an electromagnetic wave carrying an orbital angular momentum. The method includes, for at least one data symbol to be transmitted: a bijective selection of an order of orbital angular momentum associating, with each distinct value of a data symbol, a distinct order of orbital angular momentum, and delivering a selected order of orbital angular momentum that is representative, by bijection, of the value of the at least one data symbol to be transmitted; and transmitting the electromagnetic wave carrying an orbital angular momentum, the order of orbital angular momentum of which corresponds to the selected order of orbital angular momentum.
    Type: Grant
    Filed: November 28, 2014
    Date of Patent: September 25, 2018
    Assignees: Institut National des Sciences Appliquees de Rennes, Universite de Rennes 1, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Philippe Mary, Adbullah Haskou, Christian Brousseau
  • Publication number: 20180136299
    Abstract: The invention relates to a module (6) for producing an MRI and/or MRS reference signal (S0), characterized in that the module comprises: a first receiving input (621) for receiving of an MRI and/or MRS synchronization signal (S3), a second receiving input (612) for receiving of a time signal (S8) of external stimulation, supply means (62) for supplying of a prescribed signal (RV) representing an MRI and/or MRS virtual object (RVV), generating means for generating of the MRI and/or MRS reference signal (S0), for temporally varying the MRI and/or MRS reference signal (S0) in the same way as a time characteristic determined from the time signal (S8) of external stimulation and in synchronization with the MRI and/or MRS synchronization signal (S3), a supply output (632) for supplying of the MRI and/or MRS reference signal (S0).
    Type: Application
    Filed: April 1, 2016
    Publication date: May 17, 2018
    Applicants: Universite De Rennes 1, Institut National de la Sante et de la Recherche Medicale (INSERM), Fondat Region Ouest Ligue Cancer
    Inventors: Hervé Saint-Jalmes, Giulio Gambarota
  • Patent number: 9938456
    Abstract: This deals with a luminescent salt comprising a metal cluster anion and an organic cation, wherein the metal cluster anion comprises a metal cluster with at least two metal atoms, and ligands, the metal atoms being chosen from the group consisting of molybdenum, rhenium, tungsten, thallium, niobium, and mixtures thereof, wherein the organic cation comprises a cationic head substituted by at least one substituent including a polymerizable functional group. It also deals with a polymeric material comprising a polymer matrix which has polymerized with this luminescent salt.
    Type: Grant
    Filed: January 15, 2014
    Date of Patent: April 10, 2018
    Assignees: Universite de Rennes 1, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Yann Molard, Maria De Los Angeles Amela-cortes, Stephane Cordier
  • Publication number: 20180051130
    Abstract: 1) Hydrocarbon-based polymer of formula (I): in which F1 and F2 have the respective formulae (IIa) and (IIb) or (II?a) and (II?b): a process for its preparation, and use as an adhesive.
    Type: Application
    Filed: August 15, 2017
    Publication date: February 22, 2018
    Applicants: Bostik SA, Universite De Rennes I, Centre National De La Recherche Scientifique
    Inventors: Guillaume MICHAUD, Frederic SIMON, Stephane FOUQUAY, Elise VANBIERVLIET, Sophie GUILLAUME, Jean-Francois CARPENTIER
  • Publication number: 20180022864
    Abstract: F1 is formula (IIa) and F2 is formula (IIb): g and d are 0, 1, 2 or 3; R14 and R15 are C1-C4 or a cyclohexyl radical; R1 to R12 represents hydrogen or alkyl with 1 to 22 carbon atoms; x and y are integers, x+y is 0 to 2; R13 is oxygen or sulphur or divalent —CH2— n1, n2, m, p1 and p2 are an integer or equal to 0 and such that the molecular weight Mn of the polymer of formula (I) is between 400 and 100 000 g/mol; a process for preparation of the polymer; and use as adhesive in mixture with an amino compound with at least two amine groups.
    Type: Application
    Filed: July 18, 2017
    Publication date: January 25, 2018
    Applicants: BOSTIK SA, Universite de Rennes I, Centre National de la Recherche Scientifique
    Inventors: Guillaume MICHAUD, Frederic SIMON, Stephane FOUQUAY, Elise VANBIERVLIET, Sophie GUILLAUME, Jean-Francois CARPENTIER
  • Patent number: 9851358
    Abstract: The present invention relates to methods and pharmaceutical compositions for preventing or reducing metastatic dissemination (i.e. reducing motility of cancer cells). In particular, the present invention relates to a method for preventing or reducing metastatic dissemination (i.e. reducing motility of cancer cells) in a subject suffering from a cancer comprising the steps consisting of i) determining the expression level of at least one biomarker selected from the group consisting of soluble CD95L and EMT promoting factors in a sample obtained from the subject, ii) comparing the expression level determined at step i) with a predetermined reference value and iii) administering the subject with a therapeutically effective amount of C16-ceramide or derivatives such as C16-sphingomyelin and C16-glycosphingolipids when the expression level determined at step i) is higher than the predetermined reference value.
    Type: Grant
    Filed: January 7, 2015
    Date of Patent: December 26, 2017
    Assignees: INSERM (Institut National de la Sante et de la Recherche Medicale), Universite Paul Sabatier Toulouse III, Centre Hospitalier Universitaire de Toulouse, Universite de Bourgogne, Universite de Rennes I, Universit des Antilles et de la Guiyane, Ecole des Hautes Etudes en Sante Publique (EHESP)
    Inventors: Patrick Legembre, Bruno Segui, Thierry Levade, Olivier Micheau
  • Patent number: 9492815
    Abstract: Chalcogenide glass-ceramic having, for example, the following composition GeSe2—Sb2Se3—CuI, this glass-ceramic comprising at least one crystalline phase, characterised in that the crystallisation rate and the dimensions of the crystals in the crystalline phase are such that the crystals are substantially in contact with each other in such a way that this crystalline phase has an electrical conductivity greater than or equal to 10?4 s·cm?1 which increases under lighting due to the creation of charge carriers within the crystalline phase.
    Type: Grant
    Filed: June 19, 2013
    Date of Patent: November 15, 2016
    Assignees: Centre National de la Recherche Scientifique, Universite de Nantes, Universite de Rennes 1
    Inventors: Xianghua Zhang, Laurent Calvez, Hong Li Ma, Xianping Fan, Yang Xu, Alain Lafond
  • Patent number: 9421497
    Abstract: A method for the isotopic separation of at least two different isotopes of a body in gaseous form by: (a) converting into the form of a gas (SF6, UF6 or MoF6) the body of interest containing the sought isotope; (b) creating a flow of said gas at supersonic speed, of the laminar or slightly turbulent type; (c) exciting the molecules by laser; (d) inhibiting, by means of a laser, the nucleation of one of the isotopologs, thus forming less massive aggregates of said isotopolog than the aggregates formed by the molecules of the other isotopolog; (e) ionizing the molecules and aggregates of said gas; (f) submitting the ionized molecules and aggregates of molecules to an electromagnetic field to make the ionized molecules and aggregates of one of the isotopologs migrate towards the outside of the flow; and (g) retrieving the part of the gas flow with the highest concentration in the sought isotope.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: August 23, 2016
    Assignees: Universite De Rennes 1, Centre National De La Recherche Scientifique
    Inventors: Bertrand Rowe, Robert Georges, André Canosa, Sébastien Morales
  • Publication number: 20160098421
    Abstract: Computer tool characterised in that it comprises: a working memory (206) to receive input data, an auxiliary memory (204) to store several approximation dictionaries, a reducer (202) arranged for the iterative calculation of the approximation data of the input data, where the successive iterations are of the “matching pursuit” type, a selector (200) arranged to choose an approximation dictionary in the auxiliary memory based on a selection rule based on at least some of the preceding iterations, in which the reducer (202) calls the selector (200) in each iteration, and uses the dictionary thus selected in the adaptive matching.
    Type: Application
    Filed: December 15, 2015
    Publication date: April 7, 2016
    Applicants: Inria Institut National de Recherche en Informatique et en Automatique, Universite de Rennes 1
    Inventors: Christine Guillemot, Joaquin Zepeda, Ewa Kijak
  • Patent number: 9265706
    Abstract: The invention relates to the cosmetic use of a compound chosen from the compounds of formula (A) and the salts of same as an agent for depigmenting the skin and/or keratinous appendages.
    Type: Grant
    Filed: April 18, 2013
    Date of Patent: February 23, 2016
    Assignees: Centre National de la Recherche Scientifique—CNRS, Universite de Rennes 1, Centre Hospitalier Universitaire Pontchaillou
    Inventors: Joel Boustie, Marie-Dominique Galibert-Anne, Francoise Lohezic-le Devehat, Marylene Chollet-Krugler, Sophie Tomasi, Nicolas Mouchet, Beatrice Legouin-Gardadennec